# Mechanistic Clinical Trial of PCSK9 Inhibition for AAA

> **NCT06081153** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 44 (estimated)

## Conditions studied

- Abdominal Aortic Aneurysm

## Interventions

- **DRUG:** Evolocumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06081153
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2029-01-15
- **Final completion:** 2029-02-28
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06081153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06081153, "Mechanistic Clinical Trial of PCSK9 Inhibition for AAA". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06081153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*